TickerFactsScreenerDevelopers

Avalo Therapeutics, Inc. (AVTX) — Net Income

Annual figures by fiscal year, from SEC filings.

2013: -$13.05M2014: -$16.06M2015: -$10.49M2016: -$16.47M2017: $11.87M2018: -$40.05M2019: -$16.07M2020: -$63.50M2021: -$84.38M2022: -$41.66M2023: -$31.54M2024: -$35.13M2025: -$78.26M-$78.26M
2013Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$78.26M-122.8%
2024-$35.13M-11.4%
2023-$31.54M+24.3%
2022-$41.66M+50.6%
2021-$84.38M-32.9%
2020-$63.50M-295.1%
2019-$16.07M+59.9%
2018-$40.05M-437.4%
2017$11.87M+172.1%
2016-$16.47M-57.0%
2015-$10.49M+34.7%
2014-$16.06M-23.1%
2013-$13.05M—